Decreased infarct size after focal cerebral ischemia in mice chronically infected with Toxoplasma gondii

[1]  W. Langhans,et al.  Role for nerve growth factor in the in vivo regulation of glutathione in response to LPS in mice. , 2007, European cytokine network.

[2]  W. Langhans,et al.  Role for glutathione in the hyposensitivity of LPS-pretreated mice to LPS anorexia. , 2007, European cytokine network.

[3]  D. Arsenijevic,et al.  Induction of Ucp2 expression in brain phagocytes and neurons following murine toxoplasmosis: An essential role of IFN-γ and an association with negative energy balance , 2007, Journal of Neuroimmunology.

[4]  Q. Pittman,et al.  Peripheral Inflammation Exacerbates Damage After Global Ischemia Independently of Temperature and Acute Brain Inflammation , 2007, Stroke.

[5]  B. McColl,et al.  Systemic Inflammatory Stimulus Potentiates the Acute Phase and CXC Chemokine Responses to Experimental Stroke and Exacerbates Brain Damage via Interleukin-1- and Neutrophil-Dependent Mechanisms , 2007, The Journal of Neuroscience.

[6]  F. Crews,et al.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.

[7]  Xiang Zhu,et al.  Schistosoma japonicum egg antigens stimulate CD4+ CD25+ T cells and modulate airway inflammation in a murine model of asthma , 2007, Immunology.

[8]  A. Feldman,et al.  Coxsackievirus B3 Induces T Regulatory Cells, Which Inhibit Cardiomyopathy in Tumor Necrosis Factor-α Transgenic Mice , 2006, Circulation research.

[9]  Min-Chi Ku,et al.  Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. , 2006, Current pharmaceutical design.

[10]  Jeon-Soo Shin,et al.  Human Brain Astrocytes Mediate TRAIL-mediated Apoptosis after Treatment with IFN-γ , 2006, Yonsei medical journal.

[11]  Alun Williams,et al.  Interferon-γ increases neuronal death in response to amyloid-β1-42 , 2006, Journal of Neuroinflammation.

[12]  P. Vallet,et al.  Increased Infarct Size and Lack of Hyperphagic Response after Focal Cerebral Ischemia in Peroxisome Proliferator-Activated Receptor β-Deficient Mice , 2006, Journal of Cerebral Blood Flow and Metabolism.

[13]  M. Frotscher,et al.  Synaptic Plasticity in the Hippocampus: Effects of Estrogen from the Gonads or Hippocampus? , 2006, Neurochemical Research.

[14]  V. Perry,et al.  Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.

[15]  D. Jo,et al.  Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis , 2005, Nature Medicine.

[16]  D. Kintner,et al.  Na+-Dependent Chloride Transporter (NKCC1)-Null Mice Exhibit Less Gray and White Matter Damage after Focal Cerebral Ischemia , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  C. Bouras,et al.  Resistance to cerebral ischemic injury in UCP2 knockout mice: evidence for a role of UCP2 as a regulator of mitochondrial glutathione levels , 2004, Journal of neurochemistry.

[18]  J. Julien,et al.  Exacerbation of Motor Neuron Disease by Chronic Stimulation of Innate Immunity in a Mouse Model of Amyotrophic Lateral Sclerosis , 2004, The Journal of Neuroscience.

[19]  Wan-Wan Lin,et al.  Statins induce suppressor of cytokine signaling‐3 in macrophages , 2003, FEBS letters.

[20]  G. Tomasevic,et al.  Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma , 2003, Nature Medicine.

[21]  Sun-Hee Park,et al.  Regulatory Effect of SOCS on NF-κB Activity in Murine Monocytes/Macrophages , 2003 .

[22]  P. Tyrrell,et al.  Inflammation and Infection in Clinical Stroke , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  C. Röpke,et al.  Suppressors of cytokine signalling: SOCS , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[24]  E. Reinke,et al.  Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. , 2002, Immunology letters.

[25]  I. Campbell,et al.  Cytokine signaling in the brain: Putting a SOCS in it? , 2002, Journal of neuroscience research.

[26]  S. Melmed,et al.  The central role of SOCS-3 in integrating the neuro-immunoendocrine interface. , 2001, The Journal of clinical investigation.

[27]  P. Giannakopoulos,et al.  A role for interferon-gamma in the hypermetabolic response to murine toxoplasmosis. , 2001, European cytokine network.

[28]  S. Bates,et al.  Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisation. , 2001, Brain research. Molecular brain research.

[29]  R. Sacco.  Newer risk factors for stroke , 2001, Neurology.

[30]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[31]  J. Bach.  Protective role of infections and vaccinations on autoimmune diseases. , 2001, Journal of autoimmunity.

[32]  Y. Arsenijévic,et al.  Differential roles of tumor necrosis factor-alpha and interferon-gamma in mouse hypermetabolic and anorectic responses induced by LPS. , 2000, European cytokine network.

[33]  B. Miroux,et al.  Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production , 2000, Nature Genetics.

[34]  J B Schulz,et al.  Glutathione, oxidative stress and neurodegeneration. , 2000, European journal of biochemistry.

[35]  Bernard Dupuis,et al.  Increase in Endogenous Brain Superoxide Dismutase as a Potential Mechanism of Lipopolysaccharide-Induced Brain Ischemic Tolerance , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  G. S. Shukla,et al.  Cerebral antioxidant status and free radical generation following glutathione depletion and subsequent recovery , 2000, Molecular and Cellular Biochemistry.

[37]  P. Villoslada,et al.  Human Nerve Growth Factor Protects Common Marmosets against Autoimmune Encephalomyelitis by Switching the Balance of T Helper Cell Type 1 and 2 Cytokines within the Central Nervous System , 2000, The Journal of experimental medicine.

[38]  P. Vallet,et al.  Cell death is prevented in thalamic fields but not in injured neocortical areas after permanent focal ischaemia in mice overexpressing the anti‐apoptotic protein Bcl‐2 , 2000, The European journal of neuroscience.

[39]  D. Wright,et al.  Redox Imbalance Differentially Inhibits Lipopolysaccharide-Induced Macrophage Activation in the Mouse Liver , 1999, Infection and Immunity.

[40]  M. Mattson,et al.  Dietary restriction and 2‐deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: Evidence for a preconditioning mechanism , 1999, Journal of neuroscience research.

[41]  B. Sola,et al.  Reduction of Ischemic Damage in NGF-Transgenic Mice: Correlation with Enhancement of Antioxidant Enzyme Activities , 1999, Neurobiology of Disease.

[42]  K. Kang,et al.  Diethylmaleate and buthionine sulfoximine, glutathione-depleting agents, differentially inhibit expression of inducible nitric oxide synthase in endotoxemic mice. , 1999, Nitric oxide : biology and chemistry.

[43]  J. Flier,et al.  Activation of SOCS-3 Messenger Ribonucleic Acid in the Hypothalamus by Ciliary Neurotrophic Factor. , 1999, Endocrinology.

[44]  B. Sola,et al.  Recruitment of Several Neuroprotective Pathways after Permanent Focal Ischemia in Mice , 1998, Experimental Neurology.

[45]  Makoto Kawase,et al.  Mitochondrial Susceptibility to Oxidative Stress Exacerbates Cerebral Infarction That Follows Permanent Focal Cerebral Ischemia in Mutant Mice with Manganese Superoxide Dismutase Deficiency , 1998, The Journal of Neuroscience.

[46]  P. Ritz.  Altered energy balance and cytokine gene expression in a murine model of chronic infection with Toxoplasma gondii, Arsenijevic D, Girardier L, Syedoux J, Chang HR, Dulloo AG, in: Am J Physiol, 272. (1997), E908, (Endocrinol Metab 35) , 1997 .

[47]  H. R. Chang,et al.  Altered energy balance and cytokine gene expression in a murine model of chronic infection with Toxoplasma gondii. , 1997, The American journal of physiology.

[48]  C. Brodie.  Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes , 1996, FEBS letters.

[49]  D. Janero,et al.  Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. , 1995, Analytical biochemistry.

[50]  V. Rotter,et al.  Direct involvement of p53 in programmed cell death of oligodendrocytes. , 1995, The EMBO journal.

[51]  M. Kaste,et al.  NEW RISK-FACTORS FOR STROKE , 1988 .

[52]  J. K. Frenkel,et al.  Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis. , 1987, The American journal of tropical medicine and hygiene.

[53]  Luyang Yu,et al.  Neuroprotective Effect of A20 on TNF-Induced Postischemic Apoptosis , 2005, Neurochemical Research.

[54]  J. Cisowski,et al.  IL-1-mediated inhibition of IL-6-induced STAT3 activation is modulated by IL-4, MAP kinase inhibitors and redox state of HepG2 cells. , 2002, Folia histochemica et cytobiologica.

[55]  W. Dröge.  Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[56]  S. Rivest,et al.  Selective involvement of interleukin-6 in the transcriptional activation of the suppressor of cytokine signaling-3 in the brain during systemic immune challenges. , 2000, Endocrinology.

[57]  J. Flier,et al.  Activation of SOCS-3 messenger ribonucleic acid in the hypothalamus by ciliary neurotrophic factor. , 1999, Endocrinology.

[58]  H. R. Chang,et al.  Metabolic-cytokine responses to a second immunological challenge with LPS in mice with T. gondii infection. , 1998, The American journal of physiology.

[59]  E. Pileblad,et al.  Effective depletion of glutathione in rat striatum and substantia nigra by L-buthionine sulfoximine in combination with 2-cyclohexene-1-one. , 1990, Life sciences.